UnitedHealth Group and Amedisys have mutually agreed to waive their right to terminate their $3.3 billion merger agreement, potentially delaying the transaction until late 2025. The deal, initially expected to close in December 2024, has faced regulatory hurdles, including a lawsuit from the U.S. Department of Justice. The waiver remains effective until 10 business days after a final court ruling on the lawsuit or December 31, 2025, with a regulatory break fee of up to $375 million tied to divestment milestones. Amedisys shares rose 4% premarket following the announcement, while UnitedHealth shares remained stable.

**Source**: Seeking Alpha